drugset / Trial / NCT07226362
A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults
RandomizedCrossoverOpen-labelBasic science
Summary
A Phase 1 clinical trial to evaluate the pharmacokinetics, relative bioavailability, safety and tolerability of DHE inhalation powder delivered by dry powder inhaler, DHE IV, and DHE nasal spray.
Timeline
- Start
- 2025-06-09
- Primary completion
- 2025-10-02
- Completion
- 2025-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dihydroergotamine | Small molecule | 1 mg | Inhaled |
| Comparator | Dihydroergotamine | Small molecule | 2 mg | Inhaled |
| Comparator | Metoclopramide | Small molecule | 10 mg | Intravenous |
Indications
No indication recorded.